NCT00344916View on ClinicalTrials.gov

Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
Liver Cirrhosis
Interventions
DRUG

Ng-monomethyl-L-arginine (drug)

All Listed Sponsors
lead

Regional Hospital Holstebro

OTHER

NCT00344916 - Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis | Biotech Hunter | Biotech Hunter